Livzon Pharmaceutical
Livzon Pharmaceutical Group Inc., commonly referred to as Livzon, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Founded in 1992, the company has established a strong presence in various operational regions, focusing on the development, manufacturing, and marketing of innovative pharmaceutical products. Specialising in areas such as biopharmaceuticals, traditional Chinese medicine, and chemical pharmaceuticals, Livzon is recognised for its commitment to quality and research-driven solutions. The company’s core offerings include a range of therapeutic agents, particularly in the fields of oncology and infectious diseases, which distinguish it in a competitive market. With a robust market position, Livzon has achieved significant milestones, including numerous product approvals and collaborations that enhance its global footprint. The company continues to advance its mission of improving health outcomes through innovative therapies and a dedication to excellence in pharmaceutical development.
DitchCarbon Score
How does Livzon Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Livzon Pharmaceutical's score of 50 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Livzon Pharmaceutical's reported carbon emissions
In 2023, Livzon Pharmaceutical reported total carbon emissions of approximately 514,332,930 kg CO2e, with Scope 1 emissions at about 155,807,280 kg CO2e and Scope 2 emissions at approximately 358,525,650 kg CO2e. The company has demonstrated a commitment to reducing its carbon footprint, aiming for net-zero emissions by 2050 across all scopes. Additionally, Livzon has set a target for carbon neutrality specifically for Scope 1 and Scope 2 emissions by 2055. In 2024, the total emissions increased slightly to about 521,159,370 kg CO2e, with Scope 1 emissions at approximately 194,440,580 kg CO2e, Scope 2 at around 326,718,790 kg CO2e, and a significant Scope 3 contribution of about 1,709,496,180 kg CO2e. This highlights the importance of addressing emissions across all scopes in their sustainability strategy. Livzon's emissions data reflects a proactive approach to climate commitments, aligning with industry standards for greenhouse gas reduction and demonstrating a long-term vision for sustainability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 30,427,800 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 543,952,500 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Livzon Pharmaceutical is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
